Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04439786
Other study ID # 2020SDU-QILU-021
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date July 1, 2020
Est. completion date December 31, 2020

Study information

Verified date June 2020
Source Shandong University
Contact Jing Liu, MD
Phone +86-18560083755
Email liujingqilu@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

intravenous infusion of lidocaine significantly reduce fatigue and pain and improve the patients satisfaction after sedation for colonoscopy.


Description:

This study divide patients into two groups, lidocaine group one will be given lidocaine intravenously; control group will be given saline . the difference between patients fatigue and pain will be compared. and the propofol consumption, pain after infusion of propofol, patients, endoscopists and anaesthesist satifaction, the incidence of hypotenstion, hypoxia, and bradycardia will aslo be compared between the two groups.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 31, 2020
Est. primary completion date December 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

Inclusion Criteria: patients aged >18 years who were scheduled for colonscopy at Qilu hospital.

Exclusion Criteria:patients with ASA (American Society of Anesthesiologists) Class 4 or 5, pre-existing hypoxemia (SpO2 <90%), hypotension (systolic blood pressure <90 mm Hg), bradycardia (HR<50 beats/min), uncontrolled hypertension (SBP >170 mm Hg, diastolic blood pressure>100 mm Hg), severe renal or liver failure, pregnancy or lactation, allergy to lidocaine, atrioventricular block, epilepsy, and inability to give informed consen

-

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
placebo
the control group will be given the same volume of saline.
lidocaine
the experimental group will be given 1-1.5mg/kg lidocaine and then 2mg/kg/h

Locations

Country Name City State
China Department of Gastroenterology, Qilu Hospital, Shandong University Jinan Shandong

Sponsors (1)

Lead Sponsor Collaborator
Shandong University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other infusion pain when adminstrate propofol infusion pain was divided into no pain, mide pain and severe pain half a year
Other Safety assessed by the rate of hypoxia during the procedure Safety assessed by the rate of hypoxia during the procedure Hypoxia, defined as peripheral oxygen saturation <90% for >10 seconds half a year
Other Safety assessed by the rate of hypotention during the procedure Hypotension, defined as systolic blood pressure <90 mmHg half a year
Other Safety assessed by the rate of breadycardia during the procedure Bradycardia, defined as heart rate <50 beats/min half a year
Other Safety assessed by the rate of required airway management during the procedure Required airway management such as jaw lifting, mask ventilation, or tracheal intubation in severe hypoxia Required airway management such as jaw lifting, mask ventilation, or tracheal intubation in severe hypoxia half a year
Other Safety assessed by the rate of involuntary movement Involuntary movements, defined as unconscious movements requiring restraint or severe limb movement half a year
Other endoscopists satisfaction assessed by the performer the endoscopists satisfacition score were assessed on a 0-10VAS after the procedure half a year
Other patient satisfaction assessed by the patient the patient satisfacition score were assessed on a 0-10VAS 30mins after the procedure half a year
Other anesthetist satisfaction assessed by the anesthestist the anesthetist satisfacition score were assessed on a 0-10VAS after the procedure half a year
Primary fatigue score after colonoscopy fatigue were measured on a 0-10VAS at arrival in the recovery room ,30min later half a year
Secondary pain socre after colonoscopy pain were measured on a 0-10VAS at arrival in the recovery room ,30min later half a year
See also
  Status Clinical Trial Phase
Recruiting NCT03399019 - Bispectral Index(BIS) on Depth of Sedation With Dexmedetomidine, Propofol and Midazolam During Spinal Anesthesia N/A
Completed NCT03220880 - Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures
Recruiting NCT04820205 - Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Procedural Sedation in Children N/A
Recruiting NCT04549623 - End-Tidal Carbon Dioxide Monitoring Device for Sedation During Endoscopic Ultrasonography N/A
Recruiting NCT04822064 - Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Rescue After Failed Pediatric Procedural Sedation N/A
Completed NCT01001533 - Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation N/A
Completed NCT01527903 - A Comparison Between Propofol-Remifentanil and Midazolam-Remifentanil Sedation in the Intensive Care Unit Phase 4
Completed NCT00747721 - Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU Phase 1
Completed NCT00158873 - Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects Phase 4
Terminated NCT00205517 - Sedation and Psychopharmacology in Critical Care N/A
Recruiting NCT04096768 - The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation Phase 3
Active, not recruiting NCT05082623 - The Effect of Music on Delirium, Pain, Need of Sedation, Anxiety and Vital Parameters N/A
Suspended NCT03285165 - Cerebral Vascular Effects of Dexmedetomidine Versus Propofol Sedation in Intubated Mechanically Ventilated ICU Patients Phase 2/Phase 3
Active, not recruiting NCT04788589 - Sedation and Ventilator Weaning Protocol in PICU N/A
Completed NCT03425474 - Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy Phase 3
Recruiting NCT06061159 - The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction Phase 4
Completed NCT06449365 - Comparison of Intravenous V/S Nasal Atomizer Delivery of Midazolam for Conscious Sedation for No-scalpel Vasectomy Phase 4
Completed NCT02171910 - Doxapram as an Additive to Propofol Sedation in Sedation for ERCP Phase 4
Completed NCT02211118 - Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD Phase 4
Completed NCT01694745 - EUROpean Pain Audit In Neonates N/A